デフォルト表紙
市場調査レポート
商品コード
1507901

ePRO、電子患者日誌、eCOAの世界市場

ePRO, E-Patient Diaries and eCOA

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 411 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
ePRO、電子患者日誌、eCOAの世界市場
出版日: 2024年07月05日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 411 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のePRO、電子患者日誌、eCOAの市場規模は、2030年までに47億米ドルに達する見込み

世界のePRO、電子患者日誌、eCOAの市場規模は、2023年に18億米ドルに達し、2023~2030年の分析期間中にCAGR 15.0%で成長し、2030年には47億米ドルに達すると予測されます。ePROs分野の成長率は、分析期間中、CAGR 16.7%と推定されます。

米国市場は6億2,980万米ドル、中国はCAGR 17.9%で成長予測

米国のePRO、電子患者日誌、eCOAの市場規模は、2023年に6億2,980万米ドルに達し、世界第2位の経済大国である中国は、2030年までに6億460万米ドルに達すると予測され、2023~2030年の分析期間中はCAGR 17.9%で成長する見込みです。その他の注目すべき地域別市場としては、日本とカナダがあり、それぞれ分析期間中に12.4%と14.3%のCAGRで成長すると予測されています。欧州では、ドイツがCAGR約13.6%で成長すると予測されています。

世界のePRO、電子患者日誌、eCOA市場 - 主要動向と促進要因まとめ

ePRO、電子患者日誌、eCOAは、臨床試験や医療現場で患者から直接データを収集するために使用されるデジタルプラットフォームです。ePROシステムは、健康状態、治療アドヒアランス、症状に関する患者データを、通常はモバイルデバイスやその他のウェブベースのアプリケーションを介して電子的に収集するために使用されます。電子患者日誌は、患者が自分の健康状態について日々の観察を記録するデジタル手段を提供するもので、慢性疾患の管理には特に有用です。eCOAはこれらのツールを包含し、デジタルインターフェースを通じて収集された臨床医報告アウトカム(ClinROs)、観察者報告アウトカム(ObsROs)、パフォーマンスアウトカム(PerfOs)を含みます。これらのツールは、データ収集の正確性を向上させ、患者の関与を強化し、複雑な健康データをリアルタイムで収集するプロセスを合理化することを目的として、紙ベースの方法に取って代わるように設計されています。

ePRO、電子患者日誌、eCOAシステムの導入は、ヘルスケアのデジタルトランスフォーメーションと製薬産業が患者中心の研究を重視することによって推進されています。これらのデジタルツールを活用することで、臨床研究者はより信頼性の高いデータをタイムリーに入手し、臨床試験の質と効率を高めることができます。また、これらのテクノロジーは、プロトコールの遵守を確実にし、リアルタイムのモニタリングや監査機能を促進することで、規制遵守をサポートします。患者にとっては、デジタルツールは自宅から試験に参加できる利便性を提供し、タイムリーなリマインダーやヘルスケアプロバイダーとの容易なコミュニケーションチャネルを通じて、試験プロトコルの遵守を向上させる。さらに、これらのテクノロジーは、長期にわたる一貫した患者参加と正確なデータ収集が重要な長期試験には不可欠です。

ePRO、電子患者日誌、eCOA市場の成長は、モバイル健康アプリケーションの技術的進歩や遠隔医療実践の受け入れ拡大など、いくつかの要因によってもたらされます。スマートフォンやタブレットが普及するにつれ、より多くの患者や臨床医が洗練された健康モニタリングツールに簡単にアクセスできるようになっています。規制機関や保健当局は、臨床転帰の改善におけるリアルタイムの患者データの価値をますます認識するようになっており、これが世界のヘルスケアや研究環境でのこれらのシステムの採用を後押ししています。さらに、患者中心の治療アプローチに対する需要の高まりと、臨床試験における効率的なデータ管理の必要性が、この市場の主な促進要因となっています。医療技術に対する消費者の行動は劇的に変化しており、患者は現在、自分の健康管理により積極的な役割を期待しており、これはePRO、電子患者日誌、eCOAの機能とよく一致しています。これらの動向は、パンデミック後のデジタルヘルスソリューションの継続的な推進と相まって、市場のダイナミックな拡大と進化を裏付けています。

調査対象企業の例(全85件)

  • Anju Software, Inc.
  • ArisGlobal LLC
  • Castor EDC
  • Clario
  • Climedo Health GmbH
  • ClinCapture
  • Dassault Systemes SE
  • eClinical Solutions LLC
  • ICON plc
  • IQVIA Holdings, Inc.
  • Kayentis, SAS
  • MedNet Solutions, Inc.
  • Signant Health
  • TransPerfect

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他の欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP11846

Global ePRO, E-Patient Diaries and eCOA Market to Reach US$4.7 Billion by 2030

The global market for ePRO, E-Patient Diaries and eCOA estimated at US$1.8 Billion in the year 2023, is expected to reach US$4.7 Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2023-2030. eClinical Outcome Assessments (eCOAs), one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the ePatient Reported Outcomes (ePROs) segment is estimated at 16.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$629.8 Million While China is Forecast to Grow at 17.9% CAGR

The ePRO, E-Patient Diaries and eCOA market in the U.S. is estimated at US$629.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$604.6 Million by the year 2030 trailing a CAGR of 17.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.4% and 14.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.6% CAGR.

Global ePRO, E-Patient Diaries and Ecoa Market- Key Trends and Drivers Summarized

Electronic Patient-Reported Outcomes (ePROs), e-Patient Diaries, and electronic Clinical Outcome Assessments (eCOAs) are digital platforms used in clinical trials and healthcare settings to collect data directly from patients. ePRO systems are used to electronically capture patient data on health status, treatment adherence, and symptoms, usually via mobile devices or other web-based applications. E-Patient Diaries provide patients with a digital means to record daily observations about their health condition, which can be particularly valuable for chronic diseases management. eCOAs encompass these tools and extend to include clinician-reported outcomes (ClinROs), observer-reported outcomes (ObsROs), and performance outcomes (PerfOs) gathered through digital interfaces. These tools are designed to replace paper-based methods, aiming to improve the accuracy of data collection, enhance patient engagement, and streamline the process of capturing complex health data in real time.

The adoption of ePRO, e-Patient Diaries, and eCOA systems is being propelled by the digital transformation in healthcare and the pharmaceutical industry’s focus on patient-centered research. By utilizing these digital tools, clinical researchers can obtain more reliable and timely data, enhancing the quality and efficiency of clinical trials. These technologies also support regulatory compliance by ensuring adherence to protocols and facilitating real-time monitoring and auditing capabilities. For patients, digital tools offer the convenience of participating in studies from home and improve compliance with study protocols through timely reminders and easier communication channels with healthcare providers. Moreover, these technologies are integral in long-term studies where consistent patient engagement and accurate data collection over extended periods are crucial.

The growth in the ePRO, e-Patient Diaries, and eCOA market is driven by several factors, including technological advancements in mobile health applications and increased acceptance of telehealth practices. As smartphones and tablets become more prevalent, more patients and clinicians are able to access sophisticated health monitoring tools with ease. Regulatory bodies and health authorities are increasingly recognizing the value of real-time patient data in improving clinical outcomes, which is encouraging the adoption of these systems across global healthcare and research settings. Additionally, the growing demand for patient-centric treatment approaches and the need for efficient data management in clinical trials are key drivers of this market. Consumer behavior towards health technology has shifted dramatically, with patients now expecting more active roles in managing their health, which aligns well with the capabilities of ePROs, e-Patient Diaries, and eCOAs. These trends, combined with the ongoing push for digital health solutions post-pandemic, underscore a dynamic expansion and evolution in the market.

Select Competitors (Total 85 Featured) -

  • Anju Software, Inc.
  • ArisGlobal LLC
  • Castor EDC
  • Clario
  • Climedo Health GmbH
  • ClinCapture
  • Dassault Systemes SE
  • eClinical Solutions LLC
  • ICON plc
  • IQVIA Holdings, Inc.
  • Kayentis, SAS
  • MedNet Solutions, Inc.
  • Signant Health
  • TransPerfect

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Pivotal Role of eCOA, ePRO and Patient Engagement in Transforming Patient Centricity
    • An Introduction to ePRO, E-Patient Diaries and eCOA
    • Influencer Market Insights
    • Global Economic Update
    • Global Market Outlook
    • eCOA: The Largest Category
    • ePRO Offers Tremendous Opportunities in Improving Healthcare System
    • Competition
    • ePRO, E-Patient Diaries and eCOA - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Digitalization of Healthcare Services and Rising Importance of Electronic Data Capture Technologies to Fuel Market Growth
    • Global Digital Health Market: Annual Revenues in US$ Million by Region/Country for 2020 and 2027
    • Patient Engagement Practices of the Future to be Shaped by Trends of Increased Use of Personal Devices and Passive Data
    • Key Patient Engagement Technology Trends and Innovations
    • eCOA & ePRO: A Powerful Duo Serving Clinical Trials with Electronic Data Collection
    • Rise in Clinical Trials Drives Need for ePRO, ePatient Diaries, and eCOA Solutions
    • Number of Registered Clinical Studies (in Thousands) Worldwide for the Period 2010-2023
    • Clinical Trials in the US: % Change in Trial Starts by Therapy Area for 2020 Vs 2019
    • Percentage Breakdown of Endpoint Adjudication Committees (EAC) Trials by Therapeutic Area: 2023E
    • COVID-19 Pandemic Triggers Technology Adoption in Clinical Trials
    • Digital Health Venture Funding in the US (in $ Billion) for the Years 2015-2023
    • Trends in Clinical Trials Space to Influence Market Demand
    • Shift towards Decentralized/Virtual Clinical Trials to Boost Market Prospects
    • Global Virtual Clinical Trials Market Size (in US$ Billion) for the Years 2022, 2024, 2026 and 2028
    • Global Virtual Clinical Trials Market by Indication (in %) for 2023E
    • Decentralized Clinical Trials Driving Greater Demand for Patient-Centric Drug Development
    • Role of eCOA & ePRO in Enhancing Data Accuracy of Decentralized Clinical Trials
    • Growing Volumes of Data Generation in Decentralized Trials: A Challenge
    • Adoption of Digital Technologies in Contract Research Organizations Bodes Well for the Market
    • Global Contract Research Outsourcing Market Revenues (US$ Million) by Geographic Region/Country for 2020 and 2027
    • Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
    • COVID-19 and Implications for Drug Development Regulations & Processes
    • Rise in Telemedicine Services Present Market Opportunities
    • Global Telehealth Market (In US$ Million) for Years 2022, 2024, 2026 and 2028
    • Growing Adoption of Mobile Technologies and BYOD Trend in Healthcare Industry Boosts Market Prospects
    • Smartphone Adoption Rate as a Percentage of Connections by Region for 2022 and 2030
    • Mobile Device Use in Healthcare Settings: % Usage by Type of Mobile Device
    • Electronic Patient Record (ePRO) Solutions Emerge as Ideal Replacements for Paper-Based PRO systems
    • Moving over Paper Pains & Mastering the Art of Real-Time Data Collection with ePRO
    • Delivering Better Data: A Key Benefit of ePRO
    • Factors Ensuring Success of ePRO Implementations
    • ePatient Reported Outcomes (PROs) Gain Importance in Oncology Studies
    • Advances in ePRO Technologies Promise Better Clinical Decision Making in Healthcare Systems
    • Integrating AI into ePRO Improves the Efficiency of ePRO Data Collection and Assessment
    • Data Integrity, Security & Privacy: Key Priorities for ePRO Solutions
    • Electronic Clinical Outcome Assessment Solution (eCOA) Market: Poised for Growth
    • Global eCOA Market Breakdown by Delivery Mode (in %) for 2023E
    • eCOA Usage by Clinical Trial Phase (in %) for 2021
    • eCOA Grants The Best Route to Improve Data Quality & Patient Experience for Clinical Trials
    • Benefits Offered by eCOA Systems over the Paper-Based Systems in Trials
    • How to Successfully Implement eCOA Systems in Clinical Trials?
    • New Technologies & Approaches with Potential to Augment Statistical Prowess of eCOA
    • Technological Trends Transforming eCOA Solutions Market
    • Future Trends in eCOA Market: A Review
    • UAT, Challenges and Embedded UAT for eCOAs
    • Benefits of BYOD for eCOAs
    • E-Patient Diaries: Significant Advantages over Paper Diaries to Drive Market
    • Major Benefits of ePatient Diary
    • eCOA & ePRO to Help Mental Health Research Shed the Taboo Status & Move Forward
    • Intriguing Perks of eCOA & ePRO for Mental Health Research
    • Increase in Healthcare Spending to Propel Demand
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Increasing Burden of Chronic Diseases and Focus on Drug Development, Therapies and Vaccines Boost Market
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Aging World Population to Drive Market Growth
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Challenges Facing Companies Implementing eCOA, ePRO & Patient-Centric Clinical Trials
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World ePRO, E-Patient Diaries and eCOA Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for eClinical Outcome Assessments (eCOAs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for eClinical Outcome Assessments (eCOAs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for ePatient Reported Outcomes (ePROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for ePatient Reported Outcomes (ePROs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Clinician Reported Outcomes (ClinROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Clinician Reported Outcomes (ClinROs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for ePatient Diaries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for ePatient Diaries by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Performance Outcomes (PerfOs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Performance Outcomes (PerfOs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Observer Reported Outcomes (ObsROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Observer Reported Outcomes (ObsROs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Clinical Trial Sponsors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Clinical Trial Sponsors by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World 7-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 25: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • ePRO, E-Patient Diaries and eCOA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: USA 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Canada 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030
  • JAPAN
    • TABLE 34: Japan Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Japan 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Japan 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030
  • CHINA
    • TABLE 38: China Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: China 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030
  • EUROPE
    • ePRO, E-Patient Diaries and eCOA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 42: Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 43: Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030
  • FRANCE
    • TABLE 48: France Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: France 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
    • TABLE 50: France Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030
  • GERMANY
    • TABLE 52: Germany Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Germany 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
    • TABLE 54: Germany Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Germany 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030
  • ITALY
    • TABLE 56: Italy Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Italy 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
    • TABLE 58: Italy Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Italy 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030
  • UNITED KINGDOM
    • TABLE 60: UK Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: UK 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
    • TABLE 62: UK Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: UK 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 64: Rest of Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Rest of Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
    • TABLE 66: Rest of Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Rest of Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030
  • ASIA-PACIFIC
    • ePRO, E-Patient Diaries and eCOA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Asia-Pacific 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
    • TABLE 70: Asia-Pacific Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Asia-Pacific 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 72: Rest of World Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 73: Rest of World 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for eClinical Outcome Assessments (eCOAs), ePatient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2024 & 2030
    • TABLE 74: Rest of World Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of World 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2024 & 2030

IV. COMPETITION